reconstitution protocol FAQ

Withdraw the needle, invert the vial, and use a fresh sterile syringe to carefully draw out the excess air through the rubber stopper. Insert the needle, allow air to escape until you see liquid at the needle hub, then withdraw. Excess air creates positive pressure inside the vial, which forces solution out through the needle track when you attempt future draws and increases contamination risk. It also accelerates oxidative degradation of the peptide by increasing the air-to-liquid interface area inside the vial.

A clear, colorless solution is the standard. Cloudiness that doesn't resolve after swirling indicates incomplete dissolution or aggregation. Discoloration (yellow, brown, or pink tint) signals oxidative degradation. NAD+ breakdown produces nicotinamide and ADP-ribose, which can cause color shifts. Do not use discolored solutions. Cloudiness combined with discoloration almost always indicates storage failure before reconstitution (temperature excursion or moisture ingress). Contact your supplier. Real Peptides guarantees purity and stability for all research-grade peptides when stored correctly.

Discard the vial immediately. Cloudiness indicates peptide aggregation that cannot be reversed. The aggregates are insoluble peptide clumps formed when mechanical stress or improper pH caused the tetrapeptide chains to misfold and stick together. These aggregates have no biological activity and can trigger immune responses in vivo. Aggregation most commonly results from shaking the vial, injecting solvent directly onto the powder, or using saline instead of bacteriostatic water.

Extend the passive dissolution period to 30 minutes refrigerated and swirl gently every 10 minutes. Residual undissolved material after 30 minutes indicates either insufficient bacteriostatic water volume (verify you added the full specified amount) or peptide aggregation from prior temperature mishandling during shipping. Never add heat or increase agitation. Both accelerate degradation faster than they improve solubility.

Use a medical-grade cooling case rated for 2–8°C maintenance. Standard coolers with ice packs create temperature fluctuations (freezing when in direct contact with ice, warming when ice melts) that are worse than stable room temperature. The FRIO wallet and similar evaporative cooling systems maintain 2–8°C for 36–48 hours without electricity. These are the same systems used for insulin transport and meet pharmaceutical cold chain standards. If you're flying, reconstituted peptides are TSA-compliant in carry-on luggage when accompanied by a doctor's note or research documentation.

Stop immediately and set the vial upright without further agitation. Wait 5–10 minutes for foam to settle, then visually inspect the solution. If the liquid appears clear with no persistent foam layer at the top, the peptide likely survived with minimal denaturation. If foam persists or you see cloudiness that wasn't present before shaking, a portion of the peptide has denatured. You can still use the vial, but expect reduced potency. Possibly 20–30% lower than the labelled concentration. For research applications requiring precise dosing, this vial should be discarded and replaced.

Discard the solution and start over with a new vial. Shaking introduces shear forces that cause irreversible peptide fragmentation—you cannot 'fix' this by letting it sit or refrigerating it. The damage occurs at the molecular level within seconds of agitation. While the solution will still look clear and normal, bioavailability testing consistently shows 18–24% reduction in active peptide concentration after even brief shaking. There's no reliable way to assess structural integrity without mass spectrometry, so the only safe approach is to treat any shaken vial as compromised. This is an expensive mistake, but using degraded peptide wastes both the compound and the entire research protocol built around it.

Discard it. There's no salvage protocol. Peptides stored at room temperature for 8+ hours undergo irreversible denaturation that neither appearance nor home testing can detect. The solution may still look clear, but LC-MS analysis would show fragmented amino-acid chains and loss of tertiary protein structure. Research protocols treat any unrefrigerated exposure beyond 4 hours as a total loss, and that's the standard you should apply at home.

Do not shake the vial. That makes clumping worse by compacting the aggregates. Instead, gently tilt the vial at a 45-degree angle and roll it slowly between your palms for 30 seconds. This creates low-shear rotational mixing that hydrates clumped powder without mechanical disruption. If clumping persists, place the vial in the refrigerator and allow it to sit overnight. Cold temperatures slow molecular motion and can reverse loose aggregates. Never use a vortex mixer or ultrasonic bath to speed dissolution; those methods denature peptides through cavitation and heat generation.

Wait another 3–5 minutes before attempting any intervention. Some lyophilised peptide cakes are denser than others depending on the freeze-drying parameters used during manufacture, and complete hydration can take up to 10 minutes in rare cases. If visible particles remain after 10 minutes of passive dissolution, gently roll the vial between your palms for 15–20 seconds—do not shake. If particles still persist after gentle rolling, the lyophilisation process may have created aggregates that won't dissolve properly, or the vial may have been exposed to temperature excursions during shipping that partially denatured the peptide before you even opened it. Do not use a solution containing visible particles—particulate contamination indicates either manufacturing defects or degradation, neither of which is salvageable.

Use a validated pharmaceutical cold chain container with continuous temperature logging. Not a household cooler with gel packs. The container must maintain 2–8°C for the full transport duration without temperature excursions above 8°C. Pre-chill the container for 2 hours before loading the vial, and verify temperature stability with a calibrated probe thermometer before sealing. Any transport duration exceeding 6 hours requires a container with active refrigeration, not passive insulation.

The air itself is not immediately harmful, but it increases internal pressure, which forces solution back through the needle tract when you withdraw the syringe. This creates a contamination pathway between the vial's interior and the external environment. To minimize risk, inject air only after you've withdrawn liquid, never before, and always withdraw the needle slowly while maintaining slight positive pressure on the plunger. If you've already injected air and the vial now contains a large headspace bubble, vent the excess pressure by inserting a sterile needle briefly to allow air to escape before the next withdrawal.

Use a validated cold-chain transport container that maintains 2–8°C for the entire transit duration. Most laboratory-grade peptide coolers use phase-change materials or gel packs pre-conditioned to 4°C. These maintain the target range for 24–48 hours depending on ambient temperature. Never transport reconstituted peptides in a standard insulated bag with ice packs, as ice packs at 0°C can cause localized freezing at the vial wall, which denatures peptides just as effectively as heat exposure.

The peptide has lost approximately 10–20% potency due to accelerated oxidative degradation at ambient temperature. Aqueous peptide solutions degrade exponentially outside refrigeration. The first hour causes more damage than the next 12 hours under proper storage. If this was a one-time lapse and the solution still appears clear and colorless, it remains usable but at reduced strength. For dose-sensitive studies, discard it and reconstitute fresh peptide, refrigerating within 15 minutes this time.

Discard the vial immediately. Cloudiness indicates bacterial contamination or particulate matter, and yellow discoloration suggests oxidation has already begun. Glutathione in proper solution is clear to very pale straw-colored; any opacity or color shift beyond that signals compromised potency. Do not attempt to salvage it by filtering or refrigerating. Oxidized glutathione has diminished antioxidant capacity and introduces unpredictable variables into research protocols.

Proceed with reconstitution but extend passive dissolution time to 8–10 minutes before any rotation. Direct injection increases aggregation risk but doesn't guarantee failure. Check the final solution carefully. If you see visible particles, cloudiness, or precipitate after 10 minutes of settling, the batch is compromised. Clear solution indicates successful reconstitution despite suboptimal technique.

The peptide is likely compromised, though the damage may not be visually apparent. Shaking introduces mechanical shear stress that fragments peptide structures. Studies show this causes measurable potency loss in compounds under 5,000 Daltons (TB-4 is 4,963 Daltons). If you caught the mistake within the first 5–10 seconds and the solution still appears clear, you may proceed with caution, but expect reduced bioactivity. For critical research, reconstitute a fresh vial using proper technique.

Place the vial in the refrigerator at 2–8°C for 15 minutes, then resume gentle swirling. Persistent particulates after this cooling period indicate either moisture exposure during storage (causing partial pre-hydration and clumping) or insufficient bacteriostatic water volume. Do not increase agitation or add heat. Both will degrade the peptide. If particles remain after extended refrigerated swirling, the powder may have been compromised before reconstitution and should not be used.

Transport requires maintaining 2–8°C throughout transit. Use a medical-grade cooler with ice packs or gel packs rated to hold temperature for the expected travel duration. Most insulin travel cases maintain this range for 36–48 hours. Do not allow the vial to freeze (temperature below 0°C causes ice crystal formation that ruptures peptide structures). If ambient temperature exceeds 25°C for more than 4 hours, the peptide begins to degrade measurably. Laboratories shipping reconstituted samples use cold-chain logistics with continuous temperature monitoring.

Lyophilised SS-31 tolerates room temperature storage (20–25°C) for up to 30 days without significant degradation. The peptide is stable in dry powder form. Extended exposure beyond 60 days at room temperature or any exposure above 30°C degrades the peptide through oxidative pathways that target the arginine and lysine residues. If the vial was left unrefrigerated for more than 8 weeks, request a replacement. Once reconstituted, however, the solution must be refrigerated immediately.